Stay updated on Entrectinib in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Entrectinib in Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now indicates the study is no longer recruiting and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study); it also updates the header formatting from 'Intervention / Treatment' to 'Intervention/Treatment' and includes a site revision tag (Revision: v3.6.0).
    Difference
    0.2%
    Check dated 2026-06-16T20:12:16.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now displays the latest Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a minor build update.
    Difference
    0.0%
    Check dated 2026-06-09T15:23:58.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    New date values were added (e.g., 2026-05-27 and 2027-06-30) and old dates (e.g., 2026-03-06, 2026-05-14, 2026-03-05, 2026-03) were removed, reflecting updates to the study timeline and last-updated timestamps on the record.
    Difference
    0.1%
    Check dated 2026-06-02T13:32:03.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Publications section gained a new citation for a comparative effectiveness analysis of entrectinib and crizotinib in ROS1+ NSCLC. The Erratum reference for that publication was removed and the page revision tag updated to v3.5.4.
    Difference
    0.0%
    Check dated 2026-05-19T05:27:05.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    A new bibliographic reference was added to the Publications section. It cites the 2025 NCCN Gastric Cancer guidelines (Ajani et al.).
    Difference
    0.0%
    Check dated 2026-05-12T01:49:01.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    A new PubMed-derived publication citation (about an indirect comparison of entrectinib vs. crizotinib in Asian ROS1-positive NSCLC patients) has been added to the study’s publications list. The page’s site release/version label has been updated from one revision to another.
    Difference
    0.0%
    Check dated 2026-04-27T11:51:53.000Z thumbnail image

Stay in the know with updates to Entrectinib in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.